Clofoctol


CAS No. : 37693-01-9

37693-01-9
Price and Availability of CAS No. : 37693-01-9
Size Price Stock
100mg $90 In-stock
500mg $280 In-stock
1 g Get quote
5 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-B1150
M.Wt: 365.34
Formula: C21H26Cl2O
Purity: >98 %
Solubility: H2O : < 0.1 mg/mL;DMSO : 100 mg/mL (ultrasonic)
Introduction of 37693-01-9 :

Clofoctol is a bacteriostatic antibiotic. Clofoctol is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria. Clofoctol is only functional against Gram-positive bacteria and can penetrate into human lung tissue. Clofoctol is also an inhibitor of prostate cancer. Clofoctol has antiviral potency[1][2][3]. In Vitro: Clofoctol (0-100 μM; 72 h) inhibits prostate cancer cell growth[2].
Clofoctol (0-20 μM; 24 h) arrests cell cycle at G1 phase[2].
Clofoctol (0-30 μM; 0-24 h) induces ER stress and activates UPR pathways[2].
Clofoctol (0-40 μM; 24 h) inhibits translation[2].
Clofoctol (0-100 μM; 24 h) shows antiviral effect against SARS-CoV-2 with IC50s of 9.3 μM and 11.59 μM in Vero-81 and Vero-81-TMPRSS2 cells, respectively[3]. In Vivo: Clofoctol (175 mg/kg; i.p.; daily for 37 days) is capable of blocking tumour growth without apparent toxicity in a mouse model of human prostate cancer xenograft[2].
Clofoctol (62.5 mg/kg; i.p.; twice) inhibits SARS-CoV-2 replication and lowers inflammation in lungs in mice with SARS-CoV-2 infection[3].

Your information is safe with us.